A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL WITH VEGFR2-EPITOPE PEPTIDE AND GEMCITABINE FOR PATIENTS WITH LOCALLY ADVANCED, METASTATIC, OR UNRESECTABLE PANCREATIC CANCER: PEGASUS-PC STUDY

被引：0
|
作者：
Yamaue, H. [1 ]
Miyazawa, M. [1 ]
Mizuno, N. [2 ]
Okusaka, T. [3 ]
Fukutomi, A. [4 ]
Ishii, H.
Ohkawa, S. [5 ]
Furukawa, M. [6 ]
Maguchi, H. [7 ]
Ikeda, M. [8 ]
Nishio, K. [9 ]
Ohashi, Y. [10 ]
Tsunoda, T.
机构：
[1] Wakayama Med Univ Hosp, Dept Surg 2, Wakayama, Japan
[2] Aichi Canc Ctr Hosp, Dept Gastroenterol, Aichi, Japan
[3] Natl Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[4] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[5] Kanagawa Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Kanagawa, Japan
[6] Natl Hosp Org Kyushu Canc Ctr, Dept Hepatobiliary Pancreatol, Fukuoka, Japan
[7] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan
[8] Natl Canc Ctr Hosp E, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[9] Kinki Univ, Sch Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan
[10] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo 1138654, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] Phase II/III clinical trial with VEGFR2-epitope peptide and gemcitabine for patients with locally advanced, metastatic, or unresectable pancreatic cancer: Pegasus-PC study
    Yamaue, Hiroki
    Tani, Masaji
    Miyazawa, Motoki
    Yamao, Kenji
    Mizuno, Nobumasa
    Okusaka, Takuji
    Ueno, Hideki
    Boku, Narikazu
    Fukutomi, Akira
    Ishii, Hiroshi
    Ohkawa, Shinichi
    Furukawa, Masayuki
    Maguchi, Hiroyuki
    Ikeda, Masafumi
    Nishio, Kazuto
    Ohashi, Yasuo
    Tsunoda, Takuya
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] Phase I clinical trial with VEGFR2-epitope peptide and gemcitabine for patients with advanced pancreatic cancer
    Yamaue, H.
    Miyazawa, M.
    Ohsawa, R.
    Tani, M.
    Kawai, M.
    Hirono, S.
    Ina, S.
    Tsunoda, T.
    Nakamura, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
    Evans, T. R. J.
    Van Cutsem, E.
    Moore, M. J.
    Bazin, I. S.
    Rosemurgy, A.
    Bodoky, G.
    Deplanque, G.
    Harrison, M.
    Melichar, B.
    Pezet, D.
    Elekes, A.
    Rock, E.
    Lin, C.
    Strauss, L.
    O'Dwyer, P. J.
    ANNALS OF ONCOLOGY, 2017, 28 (02) : 354 - 361
  • [4] Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC)
    Strumberg, Dirk
    Schultheis, Beate
    Ebert, Matthias Philip
    Kerkhoff, A.
    Hofheinz, Ralf Dieter
    Behringer, Dirk M.
    Schmidt, Wolfgang E.
    Goker, Erdem
    De Dosso, Sara
    Kneba, Michael
    Yalcin, Suayib
    Overkamp, Friedrich
    Schlegel, Frank
    Dommach, M.
    Rohrberg, Robert
    Steinmetz, Tilman
    Reuter, Dirk
    Bach, Ferdinand
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Parenteral Hydration in Patients With Advanced Cancer: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
    Bruera, Eduardo
    Hui, David
    Dalal, Shalini
    Torres-Vigil, Isabel
    Trumble, Joseph
    Roosth, Joseph
    Krauter, Susan
    Strickland, Carol
    Unger, Kenneth
    Palmer, J. Lynn
    Allo, Julio
    Frisbee-Hume, Susan
    Tarleton, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 111 - 118
  • [6] Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial
    Sanjay Singh Negi
    Anil Agarwal
    Adarsh Chaudhary
    Investigational New Drugs, 2006, 24 : 189 - 194
  • [7] Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial
    Negi, SS
    Agarwal, A
    Chaudhary, A
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 189 - 194
  • [8] Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial
    Stone, Patrick Charles
    Minton, Ollie
    Richardson, Alison
    Buckle, Peter
    Enayat, Zinat E.
    Marston, Louise
    Freemantle, Nick
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (20) : 2382 - 2392
  • [9] A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
    S R Bramhall
    J Schulz
    J Nemunaitis
    P D Brown
    M Baillet
    J A C Buckels
    British Journal of Cancer, 2002, 87 : 161 - 167
  • [10] A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
    Bramhall, SR
    Schulz, J
    Nemunaitis, J
    Brown, PD
    Baillet, M
    Buckels, JAC
    BRITISH JOURNAL OF CANCER, 2002, 87 (02) : 161 - 167
12345